Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
- PMID: 10675352
- PMCID: PMC377444
- DOI: 10.1172/JCI7901
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
Abstract
In lipoatrophic diabetes, a lack of fat is associated with insulin resistance and hyperglycemia. This is in striking contrast to the usual association of diabetes with obesity. To understand the underlying mechanisms, we transplanted adipose tissue into A-ZIP/F-1 mice, which have a severe form of lipoatrophic diabetes. Transplantation of wild-type fat reversed the hyperglycemia, dramatically lowered insulin levels, and improved muscle insulin sensitivity, demonstrating that the diabetes in A-ZIP/F-1 mice is caused by the lack of adipose tissue. All aspects of the A-ZIP/F-1 phenotype including hyperphagia, hepatic steatosis, and somatomegaly were either partially or completely reversed. However, the improvement in triglyceride and FFA levels was modest. Donor fat taken from parametrial and subcutaneous sites was equally effective in reversing the phenotype. The beneficial effects of transplantation were dose dependent and required near-physiological amounts of transplanted fat. Transplantation of genetically modified fat into A-ZIP/F-1 mice is a new and powerful technique for studying adipose physiology and the metabolic and endocrine communication between adipose tissue and the rest of the body.
Figures








Similar articles
-
A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes.Int J Obes Relat Metab Disord. 2000 Nov;24 Suppl 4:S11-4. doi: 10.1038/sj.ijo.0801493. Int J Obes Relat Metab Disord. 2000. PMID: 11126232 Review.
-
Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy.Diabetes. 2002 Sep;51(9):2727-33. doi: 10.2337/diabetes.51.9.2727. Diabetes. 2002. PMID: 12196465
-
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes.Diabetes. 2001 Jun;50(6):1440-8. doi: 10.2337/diabetes.50.6.1440. Diabetes. 2001. PMID: 11375346
-
Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy.Diabetologia. 2009 May;52(5):972-81. doi: 10.1007/s00125-009-1309-8. Epub 2009 Mar 10. Diabetologia. 2009. PMID: 19277603
-
Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes.Ann N Y Acad Sci. 1999 Nov 18;892:289-96. doi: 10.1111/j.1749-6632.1999.tb07802.x. Ann N Y Acad Sci. 1999. PMID: 10842669 Review.
Cited by
-
Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy.Mol Ther Methods Clin Dev. 2022 Oct 3;27:206-216. doi: 10.1016/j.omtm.2022.09.014. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36320417 Free PMC article.
-
Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.Endocrine. 2015 Jun;49(2):307-23. doi: 10.1007/s12020-015-0531-z. Epub 2015 Feb 4. Endocrine. 2015. PMID: 25645463 Review.
-
Leptin treatment has vasculo-protective effects in lipodystrophic mice.Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2110374119. doi: 10.1073/pnas.2110374119. Epub 2022 Sep 26. Proc Natl Acad Sci U S A. 2022. PMID: 36161905 Free PMC article.
-
Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.Am J Physiol Endocrinol Metab. 2012 May 1;302(10):E1283-91. doi: 10.1152/ajpendo.00511.2011. Epub 2012 Mar 6. Am J Physiol Endocrinol Metab. 2012. PMID: 22395110 Free PMC article.
-
Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.J Am Heart Assoc. 2013 Jul 31;2(4):e000312. doi: 10.1161/JAHA.113.000312. J Am Heart Assoc. 2013. PMID: 23902639 Free PMC article.
References
-
- Foster, D.W. 1994. The lipodystrophies and other rare disorders of adipose tissue. In Harrison’s principles of internal medicine. K.J. Isselbacher et al., editors. McGraw-Hill. New York, NY. 2131–2136.
-
- Seip M, Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy) Acta Paediatr Suppl. 1996;413:2–28. - PubMed
-
- Rossini, A.A., and Cahill, G.F.J. 1979. Lipoatrophic diabetes. In Endocrinology. Volume 2. L.J. DeGroot et al., editors. Grune & Stratton. New York, NY. 1093–1097.
-
- Vigouroux C, et al. Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families. J Clin Endocrinol Metab. 1997;82:3438–3444. - PubMed
-
- Peters JM, et al. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet. 1998;18:292–295. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources